|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.81 USD | +0.17% |
|
-2.68% | -36.29% |
| Mar. 20 | Cytek Biosciences Insider Sold Shares Worth $269,600, According to a Recent SEC Filing | MT |
| Mar. 19 | Cytek Biosciences Appoints William McCombe as CFO, Reaffirms 2024 Guidance | MT |
Cytek Biosciences, Inc. provided earnings guidance for the full year 2022. For the period, Company expects revenue to be closer to the high end of the range of $160 million to $168 million.
| 1st Jan change | Capi. | |
|---|---|---|
| -36.29% | 759M | |
| +8.35% | 209B | |
| +9.41% | 175B | |
| +11.75% | 131B | |
| +19.34% | 99.98B | |
| -0.84% | 61.12B | |
| +15.08% | 52.34B | |
| -2.10% | 46.5B | |
| +0.10% | 39.24B | |
| +11.50% | 38.47B |
CYTEK BIOSCIENCES, INC. 
